Assessment of Treatment of Neonatal Sepsis at Dr.Gaffar Ibnauf specialized children's hospital – Khartoum – Sudan by Ahmed, Mohammed
 University of Khartoum 
Faculty of Pharmacy 
 
Assessment of Treatment of Neonatal Sepsis at Dr.Gaffar Ibnauf 
specialized children's hospital – Khartoum – Sudan. 
 
By: 
Mohammed Ahmed Abdulrahman  Alabbas 
 
B. Pharm. (U of K) 2003 
 
A thesis submitted in partial fulfillment of the (M CP) degree 
 
Supervisors 
 
Professor: Elamin Ibrahim Elnima. 
Department of pharmaceutics 
Faculty of Pharmacy 
University of Khartoum 
 
Dr: Amani A. Norry. 
Head of pharmacy department - Dr.Gaffar Ibnauf specialized children's hospital 
– Khartoum – Sudan 
 
Khartoum 
Sudan 
October 2010 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 I
 
                  
 
Content: 
Subject 
 
Page 
No. 
Content…………………………………………………………… 
 
Dedication………………………………………………………… 
 
Acknowledgement………………………………………………… 
 
Abstract………………………………………………………….. 
 
Arabic abstract……………………………………………………. 
 
List of abbreviations …………………………………………….. 
 
List of tables……………………………………………………… 
 
 
Chapter 1: Introduction and Literature…………………………… 
 
1.1-Introduction………………………………………………….. 
1.1.1-Defintion…………………………………………………… 
1.1.2-Classification and Etiology…………………………………. 
1.1.3-Risk factors………………………………………………… 
1.1.4-Signs………………………………………………………... 
1.1.5-Investigations……………………………………………….. 
1.1.6-Treatment…………………………………………………… 
1.1.6.1-Supportive treatment……………………………………… 
1.1.6.2-Antimicrobial treatment…………………………………... 
1.1.7-Rationale…………………………………………………….  
1.1.8-Objectives………………………………………………….. 
1.2-Literature Review…………………………………………….. 
 
Chapter 2: Methodology………………………………………….. 
 
2.1-Study design………………………………………………….. 
2.2-Study area……………………………………………………. 
2.3-Study population…………………………………………….. 
2.4-Sample size………………………………………………….. 
I 
 
III 
 
IV 
 
V 
 
VII 
 
VIII 
 
X 
 
 
1 
 
1 
1 
1 
2 
3 
3 
4 
5 
6 
11 
12 
13 
 
16 
 
16 
16 
17 
17 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 II
2.5-Criteria of selection………………………………………….. 
2.6-Method……………………………………………………….. 
2.7-Data analysis………………………………………………….. 
 
 
 
Chapter 3: Result and Discussion………………………………… 
 
3.1-Results……………………………………………………….. 
 
3.2-Discussion…………………………………………………… 
 
Chapter 4: Conclusion and Recommendations……………………  
 
4.1-Conclusion…………………………………………………… 
 
4.2-Recommendations…………………………………………….. 
 
 
References………………………………………………………… 
17 
18 
19 
 
 
 
19 
 
19 
 
23 
 
31 
 
31 
 
33 
 
 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 III
 
 
 
 
 
 
 
 
 
 
 
Dedication 
 
 
 
 
To the soul of my great father…… 
 
 
 
         To my lovely mother and sisters…… 
 
 
 
                      To all who stand by me in my live……. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 IV
 
 
 
 
 
 
 
Acknowledgment: 
 
 
 
I would like to express my deepest thanks and grateful acknowledgment 
to my supervisor Professor: Elamin Ibrahim Elnima-Faculty of 
Pharmacy-University of Khartoum for his supervision and kind assistance 
and guidance and wise advices which made this research comes to light. 
 
My thanks are extended to my co-supervisor Dr. Amani Norry-Head of 
pharmacy department - Dr.Gaffar Ibnauf specialized children's hospital – 
Khartoum – Sudan for her continuous encouragement and valuable 
advices. 
 
I would like also to thank  all the staff of Dr.Gaffar Ibnauf specialized 
children's hospital – Khartoum – Sudan and specially the statistics staff at 
Dr.Gaffar Ibnauf specialized children's hospital – Khartoum – Sudan, and 
all others who supported me for conducting this research.   
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 V
 
 
 
Abstract: 
 
Introduction: Neonatal sepsis is considered as the most common cause of 
death at Dr.Gaffar Ibnauf specialized children's hospital – Khartoum – 
Sudan. Mortality rate due to neonatal sepsis at the hospital was 24% of 
the total death in the hospital. 
  
Objectives: The objective of this study was to assess the treatment of 
neonatal sepsis, to develop strategy for rational use of antibiotics to 
reduce the risk of antibiotics resistance, to evaluate the record keeping 
system and to evaluate the follow of the protocol of treatment of neonatal 
sepsis in the hospital. 
 
Methodology: The study was a retrospective study conducted at 
Dr.Gaffar Ibnauf specialized children's hospital – Khartoum – Sudan in 
the period of 9/ 2010 – 10/ 2010, tow hundred and twenty nine patients 
medication records out of 562 records were checked for type of 
antimicrobial treatment used and if supportive treatment was used, 
investigations done, duration of treatments, if the protocol was followed 
and the outcomes of these treatments. The data was analyzed using SPSS. 
 
Results: Mortality rate was found to be 21.35% from total number of 
patient admitted and diagnosed as neonatal septicemia, CBC done for all 
patients (100%), Blood culture and Urine culture were not done for any 
studied cases (0%), all cases received supportive treatment (100%), 
65.93% received Cefotaxime + Ampicillin +Cloxacillin combination was 
the most common used treatment, other combination were used with 
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variable frequencies, hospital protocol was followed in (21.9%) of the 
cases , 74.67% of patient were cured while 25.33% were dead. 
 
Conclusion: The mortality rate due to neonatal sepsis was very high, 
supportive treatment is curial and had been used for all patients, protocol 
follow-up was ignored for most of the cases and the selection of 
antimicrobial was irrational and not based on the type of the infection or 
the isolation of the causative organism, which will lead to emergence of 
resistance. The record keeping system was good enough to provide the 
required information.    
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List of abbreviations: 
 
 (GBS) = Group B Streptococcus.  
 
(E. coli) = Escherichia coli. 
 
(GI tracts) = Gastrointestinal tracts. 
 
(GU tracts) = Genitourinary tracts. 
 
 (CRP) = C - reactive protein. 
 
(WBC) = White Blood Cell. 
 
(LBW) = Low Birth Weight. 
 
(PROM) = Preterm Rupture of Membrane. 
 
(CSF) = Cerebro Spinal Fluid. 
 
 (SIRS) = systemic inflammatory response syndrome. 
 
(S. aureus) = Staphylococcus aureus. 
 
(MRSA) = methicillin-resistant S. aureus 
 
(NICU) = Neonatal intensive care unit. 
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Chapter 1: Introduction and Literature Review  
 
1.1-Introduction: 
1.1.1-Defintion: 
Neonatal sepsis is a clinical syndrome that resembles invasive infection, 
usually due to bacterial infections in the neonatal period with multiple 
signs and symptoms, sepsis is commonest cause of neonatal morbidity 
and mortality, it is estimated that 20% of all neonate develop neonatal 
sepsis1, which is responsible for 40-50% of neonatal death in developing 
countries2. 
1.1.2-Classification and Etiology: 
Neonatal Sepsis can be classified into tow main groups according to the 
onset of symptoms3: 
Early onset which is present within the early 2 days (48hours) of life and 
late onset usually present after 2 days (48hours) or more from birth date.  
Early onset is occurring during passage of the fetus through the birth 
canal. The principal organisms that cause early-onset infection include 
predominantly group B streptococcus (GBS), Escherichia coli (E. coli)4. 
The major risk factor for this type of neonatal sepsis is the asymptomatic 
colonization of the maternal gastrointestinal or genitourinary tracts5. The 
maternal GI or GU tracts are colonized by GBS in up to 30% of pregnant 
women. Risk factors for higher colonization rates include African 
American descent and diabetes6. Additional risk factors for early-onset 
infection include prolonged rupture of membranes, prematurity, male 
gender, low birth weight, maternal infection, and poor prenatal care7. 
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Late-onset infection occur after delivery, due to the organism that may be 
acquired from environment such as hospital or at home ,infections from 
common hospital pathogens, including bacteria (coagulase negative 
staphylococcal species), viruses, and fungi (Candida species).Neonates on 
antibiotics for any length of time are at higher  risk for the developing  
late-onset infection, and also infants with central intravenous catheter, 
Such as percutaneously-inserted central catheter, an umbilical arterial 
line, or an umbilical venous line. Neonates that are on ventilators for 
other reasons than sepsis may acquire an infection in the hospital 
(nosocomialinfections)8  
 
Late-onset neonatal sepsis may occur in infants after leaving  the hospital, 
so the causative organisms is similar as in early-onset sepsis, GBS, E. coli 
and other Gram-negative species9. 
 
1.1.3-Risk Factors: 
· Ruptured membrane for prolonged period of time (more than 24 
hours). 
· Prematurity associated with premature rupture of membrane. 
· Preterm labour with no adequate explanation  
· Fetal distress without adequate explanation (fetal heart rate 
abnormalities especially fetal tachycardia, passage of meconium).  
· Evidences of infection or maternal infectionn.  
· Amniotic fluid with foul smelling or malodorous baby 
· Indwelling vascular catheter. 
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1.1.4-Signs of Sepsis in the Newborn 
Signs are nonspecific and subtle and can not be used as only method for 
diagnosis of neonatal sepsis and to distinguish among causing organism, 
the common signs include: 
· Hypothermia, Fever and/or instable temperature. 
· Respiratory distress.  
· Apnoea and bradycardia  
· Cyanotic episodes and unexplained jaundice and hepatomegaly. 
·  Poor feeding, irritability,   lethargy and seizures. 
· Hypoglycemia, hyperglycemia and unstable blood sugar. 
· Abdominal distension and bile-stained aspirates  
· Skin rashes and umbilical flare. 
· Poor peripheral perfusion. 
· Pallor. 
1.1.5-Investigations: 
1.1.5.1-Full blood count: 
Differential white cell count (Normal WBC 10-30,000 x 109/L) and 
percentage left shift (immature neutrophils/total neutrophil count). If 
>20% this is moderately predictive of sepsis, low WCC especially 
with neutropenia is also suspicious of sepsis.  
1.1.5.2-Blood cultures: 
For the isolation of the causative organism and for sensitivity tests. 
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1.1.5.3-Urine routine and culture: 
For the isolation of the causative organism and for sensitivity tests. 
1.1.5.4-Chest radiograph: 
To confirm the diagnosis in some cases. 
1.1.5.5-C-Reactive Protien 
1.1.5.6-Gastric aspirate and skin/wound swabs: 
Generally done at birth only. 
1.1.5.7-Lumpur Puncture-Cerebrospinal fluid: 
Needed for all cases of late onset and some cases in early onset sepsis 
 
1.1.6-Treatment of Neonatal sepsis: 
 
Treatment of neonatal sepsis can be categorized into tow main groups: 
Supportive treatments which include (providing thermo-neutral 
environment, respiratory support, volume expanders and blood 
transfusion if needed10. 
 
And antimicrobial treatment which is used based on onset of the infection 
and the causative organism according to the sensitivity test, and the 
duration of treatment depend on the type of the infection. Standard text 
books recommend 14-day antibiotic therapy for culture-proven neonatal 
sepsis11. 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
1.1.6.1-Supportive treatment: 
The importance of supportive therapy split from the good understand of 
sepsis and the systemic inflammatory response syndrome (SIRS) with the 
subsequent effects of hypotension, diminished perfusion, 
thrombocytopenia and coagulation. Splanchnic hyperemia in premature 
infants, as seen in adults SIRS is due to sepsis10. 
 
 
For managing all sick infants effectively, electrolyte balance and fluid 
with proper observation of inputs and outputs records is crucial, with 
regular monitoring of serum electrolytes and blood glucose 
dyslectrolytemia can be avoided and euuglycemia can be maintained. 
Fluid intake can be assessed by using the volume and specific gravity of 
the urine. 
Blood pressure should be undertaken regularly and so all other vital signs 
to avoid hypotension and accompanied shock. 
Infant's condition may require some vasopressors Intropes (eg. Dopamine 
and Dobutamine) can be used12. 
Some cases may require the transfusion of frozen plasma and platelets.  
The use of these compounds must be monitored to avoid any subsequent 
complications such as fluid overload or any unpredictable outcomes. 
Central catheter must be removed if there any suspicion of sepsis and can 
be reinserted 3-5 days after stabilization of therapy.  
Good monitoring of fluid input and output will maintain good blood 
pressure and permit proper perfusion of renal and so the danger of renal 
failure will be diminished. 
All infants especially very low birth weight and preterm require 
supportive ventilation to improve respiratory status. 
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Total parental nutrition is essential for most patients and it is better to be 
tailored according to the patient needs13. 
 
 
1.1.6.2-Antimicrobial therapy:  
 
Beside to the supportive therapy to restore the vital signs, antimicrobial is 
also required for treatment of neonatal sepsis. The selection of 
antimicrobial agent is depend on the type sepsis and causative organism. 
As an example in the early onset sepsis its better to use a combination of 
agents that treat group B streptococcus as well as Gram-negative species. 
Useful agents include ampicillin and gentamicin, or ampicillin plus 
cefotaxime. They used in combination to be a broad spectrum of the most 
common pathogens in early-onset sepsis, they penetrate CNS excellently. 
Ampicillin and gentamicin is the first line for treatment of early sepsis14 .   
Gentamycin need close monitoring of renal function.  
 
For late-onset sepsis, the selection of antimicrobial should be knowledge 
of the causative organism after culture and sensitivity tests.Ampicillin 
and Gentamycin can be used empirically as in early onset neonatal sepsis 
if the causative agents are sensitive to them.                                                                              
In the presence of central line treatment should cover S. aureus and 
coagulase-negative staphylococci. 
 In case of methicillin-resistant S. aureus or MRSA in infants with line 
infections, the first lines antimicrobial will be vancomycin, plus an 
aminoglycoside such as gentamicin, for empiric coverage of Gram-
negative bacilli until the result of culture is received. 
In case of non controlled bacteremia and the sepsis is still progressed with 
adequate selection of broad spectrum antibiotics and presences of 
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fungemia the infected central line must be removed. Neonates admitted to 
neonatal intensive care unit (NICU) from community, antimicrobial used 
must cover meningitis treatment. Cephalosporin of third generation (i.e., 
cefotaxime or ceftriaxone) plus ampicillin should be included in the 
empiric therapy. 
The clinical progress and microbial result must be reviewed at 48 hours, 
stop therapy if patient is well and culture is negative, continue if there are 
signs of sepsis and culture is positive and if anaerobic infections is 
suspected add metronidazole. 
Some antibiotics were reserved for resistant organism and used after 
sensitivity test is performed (eg. Meropenem, Aztreonam and imipenem). 
For G-ve use Aztreonam, Meropenem is active against most bacteria 
except methicillin resistant saph aureus (MRSA). 
Imipenem reported to cause seizures and should be avoided in neonates. 
Guidelines for treatment of neonatal sepsis (Protocol of Gaafar Ibnauf 
specialized children's hospital-Khartoum-Sudan for management of 
neonatal sepsis): 
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Early Onset Neonatal Sepsis Late Onset Neonatal Sepsis 
First line: 
Ampicillin and Gentamycin 
First line: Flucloxacillin and Amikacin 
Staphylococcus aureus is sensitive to 
Flucloxacillin. 
Coagulase negative staphylococcus is 
resistant to Gentamycin but sensitive to 
Amikacin. 
To cover Enterococci, strep fecaelis, 
listeria and GBS Ampicillin must be 
added. 
 
Second line: Cefotaxime/Ceftazidime 
In case of meningitis and resistant 
klebsiella. 
 
Third line: 
If resistant staph or the patient is 
deteriorated or ill use Vancomycin and 
Amikacin. 
If pseudomonas is suspected use 
Piperacillin and Amikacin. 
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Duration of treatment:   
In general, empiric treatment of neonatal sepsis should be continued for 
7-10 days, providing there is improvement in the overall condition of the 
patient. In many cases, the neonate will have all the clinical features of 
sepsis and will have improved after institution of antimicrobial therapy 
but will fail to yield a positive culture. In these instances it is appropriate 
to continue a full course (7-10 days) of antibiotics, despite the absence of 
a specific organism. Longer durations (up to 3 weeks) of antibiotic 
therapy may be used in cases of pneumonia or meningitis.  
Type of infection Duration of treatment/day 
Positive septic screen and negative 
blood culture 
7 – 10 
Positive blood culture without 
meningitis 
7 – 14 
Urinary tract infection 7 – 10 
Meningitis 21 
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15],[16],[17],[18],[19] and [20. 
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1.1.7-Rationale: 
The number of patients admitted to Dr.Gaafar Ibnauf specialized 
children's hospital-Khartoum-Sudan and diagnosed as neonatal sepsis in 
the period of January 2010 up to October 2010 was 562, 120 patients 
were dead which represent 21.35% of the total number of the patients. 
Total number of patients dead in the this study period was about 500 
death, the death due to neonatal sepsis in the hospital was 120 which 
represents 24% of the total death in the hospital. 
This high percent of mortality due to neonatal sepsis reflect the fact that 
the sepsis was not managed efficiently. 
The irrational use of antibiotics in the hospital will lead to emergency of 
resistance; moreover the cost of these medications is very high compared 
to the use of Benzyl Pecillin,  Gentamycin  and other effective –low cost 
agents which considered as a burden to the hospital budget. 
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Objectives:  
 
General objective: 
 
 To assess the treatment of neonatal sepsis in Gaffar Ibnauf hospital. 
 
Specific objective: 
 
To develop strategy for rational use of antibiotics in the hospital. 
To reduce the risk of antibiotics resistance. 
To evaluate the record keeping system. 
To evaluate the follow of the protocol of treatment of neonatal sepsis in 
the hospital. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
 
1.2-Literature Review:  
 
Auranqzwb B. and Hameed A. conducted study about the Neonatal sepsis 
in hospital –born babies: bacterial isolates and antibiotic susceptibility 
patterns, the objective of the study is to determine the frequency of 
bacterial isolates from neonatal blood cultures and their susceptibility 
patterns in hospital-born babies having sepsis. It was an observational 
study carried out at Obstetrics Unit and Special Care Baby Unit of 
Khyber Teaching Hospital, Peshawar from 1st January to 31st December 
2001.This study was carried out on the neonates born and admitted in 
hospital with positive blood culture reports. Early onset neonatal sepsis  
and late onset neonatal sepsis   were defined as illness appearing from 
birth to seven days and from eight to twenty-eight days postnatal age 
respectively. The blood culture reports were analyzed by SPSS package 
and cross tabulation was done. The result of the study was found to be: 
One hundred and twelve hospital-born babies presented with sepsis. 
Sixty-seven neonates had positive cultures. Escherichia coli (E. coli) was 
the commonest organism causing EONNS (35; 77.1%) followed by 
Pseudomonas (4; 8.9%), Klebsiella (4; 8.9%) and Staphylococcus aureus 
(2; 4.4%) respectively. In the late onset neonatal sepsis E. coli (19; 
77.3%) was the commonest followed by Staphylococcus and 
Pseudomonas (2; 9% each) and Klebsiella (1; 4.5%). The gram-negative 
organisms showed high degree of resistance to commonly used 
antibiotics, ampicillin (79.3%), amoxicillin (74.6%) and ceftazidime 
(71.6%), cefotaxime (55.2%) and comparatively low resistance to 
gentamicin (43.2%), tobramycin (34.3%), imipinem (23.6%), amikacin 
(22.3%), ofloxacin and ciprofloxacin (11.9%) respectively. 
Staphylococcus aureus showed almost the same resistance to ampicillin, 
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75%, and comparatively low resistance to the rest of the antibiotics as 
compared to the gram-negative organisms. 
The concluded that Neonatal sepsis is mainly caused by gram-negative 
organisms, which are developing resistance to commonly used 
antibiotics21. 
 
B Muller-Pebody and his colleagues conduct study about the Empirical 
treatment of neonatal sepsis: are the current guidelines adequate? The 
Objectives of the study was to use national laboratory surveillance data to 
determine whether pathogens responsible for neonatal bacteraemia were 
sensitive to nationally recommended antibiotic regimens. Design All 
reports of neonatal bacteraemia received by the Health Protection 
Agency's voluntary surveillance scheme in England and Wales from 
January 2006 until March 2008, were extracted from the database. 
Organisms were ranked by frequency, and proportions susceptible to 
antimicrobials recommended for empirical treatment of neonatal sepsis 
were determined. Results There were 1516 reports of bacteraemia for 
neonates <48 h old (early-onset) and 3482 reports for neonates 2-28 days 
old (late-onset). For early-onset bacteraemia, group B streptococcus 
(GBS) was the most frequent pathogen (31%) followed by coagulase-
negative staphylococci (CoNS; 22%), non-pyogenic streptococci (9%) 
and Escherichia coli (9%). For late-onset bacteraemia, CoNS were 
isolated most frequently (45%), followed by Staphylococcus aureus 
(13%), Enterobacteriaceae (9%), E coli (7%) and GBS (7%). More than 
94% of organisms (early-onset) were susceptible to regimens involving 
combinations of penicillin with either gentamicin or amoxicillin, 
amoxicillin combined with cefotaxime or cefotaxime monotherapy. More 
than 95% of organisms (late-onset) were susceptible to gentamicin with 
either flucloxacillin or amoxicillin and amoxicillin with cefotaxime, but 
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only 79% were susceptible to cefotaxime monotherapy. Conclusions 
Current guidelines for empirical therapy in neonates with sepsis are 
appropriate. However, gentamicin-based regimens should be used in 
preference to cefotaxime-based treatments, because of lower levels of 
susceptibility to cefotaxime and the need to avoid exerting selective 
pressure for resistance. Surveillance data linked to clinical data should 
further inform rational antibiotic prescribing in neonatal units22. 
 
 
T. B. Yves liem and his colleagues conducted a study which received 24 
November 2009; returned 17 January 2010; revised 8 March 2010; 
accepted 8 March 2010 it was about variation in antibiotic use in neonatal 
intensive care units in Netherland, the Objectives of the study is to 
examine the variation in quantity and classes of antibiotics used in all 10 
tertiary care neonatal intensive care units (NICUs) in the Netherlands 
during 2005.They collect data from all tertiary care NICUs in the 
Netherlands on clinical and demographic characteristics and the type and 
quantity of systemic antibiotic use [expressed as defined daily doses 
(DDD)/100 admissions] in 2005. Antibiotics were ranked by volume of 
DDDs, and those antibiotics which accounted for 90% of the total volume 
of use [drug utilization (DU) 90%] were noted. 
They found that Antibiotic consumption ranged from 130 to 360 
DDD/100 admissions. In total, 9–24 different antibiotics were used, of 
which 3–10 were in the DU90% segment. 
They conclude that by comparing antibiotic use in Dutch NICUs they 
found a considerable variation in the number of different antibiotics used 
and in the total amount of antibiotic use. Further exploration of the 
opportunities to reach consensus in antibiotic policy, and to increase 
attention to antibiotic stewardship, is recommended23. 
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Chapter 2: 
 
Methodology:- 
 
2.1-Study design:- 
A retrospective cross-sectional study design was carried out in this 
research, the relevant data was collected from patient's files which 
contain the patients  medication records using data collecting sheet which 
include the followings:- 
-Patient file number. 
-Patient sex. 
-Patient age. 
-Investigations done: - (Complete Blood Count, Blood Culture, Urine 
Culture and sensitivity tests). 
-Antimicrobial treatment selected (Benzyl Penicillin, Gentamycin, 
Amikacin, Cefotaxime, Ceftrixone, Metronidazole, Vancomycin, 
(ampicillcin+Cloxicillin), Meropenem, Antifungal and Antiviral). 
-Duration of treatments. 
-Supportive treatment was used or not. (Yes or No). 
-Protocol was followed or not. (Yes or No). 
-Patient cured or not. 
 
2.2-Study area:- 
The study was carried at Dr.Gaafar Ibnauf specialized children's hospital-
Khartoum-Sudan. 
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2.3-Study population:- 
Patients admitted to Dr.Gaafar Ibnauf specialized children's hospital and 
diagnosed and treated for neonatal sepsis in the period from January 2010 
up to October 2010.  
2.4-Sample size:- 
 
The sample size of this study was calculated using the following 
equation:- 
 
n =           N z2 P q 
           (n-1)d2+z2  P q
 n  =       562x(1.96)2 x 0.5 x 0.5          = 
             561x(0.05)2 +(1.96 ) 2x 0.5 x 0.5 
Where: 
 N =   Population under Study.  
 n   = Sample size. 
 Z   = Value of normal curve corresponding to level of confidence (95% 
=1.96). 
 P = Proportion of target group. 
q = 1-p. 
  d = desired margin of error 5%.
From the above mentioned equation the sample size of this 
study was equal to 229. 
 
 
 
2.5-Criteria of selection:- 
 
All patients diagnosed and treated for neonatal in the period from January 
2010 up to October 2010 in all units at Dr.Gaafar Ibnauf specialized 
children's hospital-Khartoum-Sudan. 
 
229 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
2.6-Method:- 
 
Patients medication records were checked for the following:- 
-Patient file number. 
-Patient sex. 
-Patient age. 
-Investigations done: - (Complete Blood Count, Blood Culture, Urine 
Culture and sensitivity tests). 
-Antimicrobial treatment selected (Benzyl Penicillin, Gentamycin, 
Amikacin, Cefotaxime, Ceftrixone, Metronidazole, Vancomycin, 
(ampicillcin+Cloxicillin), Meropenem, Antifungal and Antiviral). 
-Duration of treatments. 
-Supportive treatment was used or not. (Yes or No). 
-Protocol was followed or not. (Yes or No). 
-Patient cured or not. 
 
2.7-Data analysis:- 
 
The data was analyzed using Microsoft Excel Sheet and SPSS. 
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Chapter 3: 
 Result and Discussion:- 
 
3.1-Results:- 
 
During the period of the study 229 files and patients medications records 
were revised and checked for the followings: 
Gender, Age, Investigations, Supportive treatment, Antimicrobial 
treatment, Duration of treatment, Protocol follow-up and Outcomes. 
The following results were obtained after analysis of data. 
 
 
Sex Frequency % 
Male 123 53.71 
Female 106 46.29 
Total 229 100 
Table No. (1)Gender 
 
 
 
Age Frequency % 
0-48 hours 20 8.73 
More than 48 hours 209 91.27 
Total 229 100 
Table No. (2) Age 
Early neonatal sepsis if age was 0 - 48 hours. 
Late neonatal sepsis if age was more than 48 hours. 
 
 
 
 
CBC Frequency % 
Done 229 100 
Not done 0 0 
Total 229 100 
Table No. (3) CBC. 
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Blood culture Frequency % 
Done 0 0 
Not dpone 229 100 
Total 229 100 
Table No. (4) Blood Culture. 
 
 
 
 
 
Urine culture Frequency % 
Done 0 0 
Not done 229 100 
Total 229 100 
Table No. (5) Urine Culture. 
 
 
 
 
 
Sensitivity test Frequency % 
Done 0 0 
Not done 229 100 
Total 229 100 
Table No. (6) Sensitivity Test. 
 
 
 
 
 
Supportive treatment Frequency % 
Provided 229 100 
Not provided 0 0 
Total 229 100 
Table No. (7) Supportive treatment. 
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Medications  used Fre
que
ncy 
% 
Bezyl  penicillin inj+Gentamycin inj 15 6.60 
Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin) 151 65.93 
Cefotaxime inj+Apmiclox inj (Cloxacillin+Ampicillin) 
+Vancomycin inj 
30 13.10 
Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin) 
+Acyclovir inj+Fluconazole inj 
1 0.20 
Cefotaxime inj+Apmiclox 
inj(Cloxacillin+Ampicillin)+Meropenem inj 
8 3.50 
Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin) 
+Metronidazole inj 
17 7.50 
Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin) 
+Amikacin 
5 2.20 
Ceftriaxone inj+ Apmiclox inj(Cloxacillin+Ampicillin) 2 0.90 
Total 229 100 
 
Table No. (8) Antimicrobials used. 
 
 
 
 
 
Duration of treatment Frequency % 
0-2 Days 40 17.46 
3-7 Days 150 65.50 
Mores than 7 days 39 17.04 
Table No. (9) Duration of treatment 
 
 
 
 
 
Outcomes Frequency % 
Cured 171 74.67 
Death 58 25.33 
Total 229 100 
Table No. (10) Outcomes. 
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Follow up of protocol Frequency % 
followed 50 21.9 
Not followed 179 78.1 
Total 229 100 
Table No. (11) Follow up of  treatment protocol. 
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3.2-Discussion: 
 
During the study period and after calculation of the sample, 229 files and 
medication records of patients diagnosed and treated for neonatal sepsis 
were checked for Gender, Age, Investigations, Supportive treatment, 
Antimicrobial treatment, Duration of treatment, Protocol follow-up and 
Outcomes. 
An epidemiological survey of neonatal sepsis in a hospital in western 
Nigeria carried out by DO Awoniyi and his colleagues they found that the 
prevalence of bacterial infection was higher in samples obtained from 
male (65%) neonates than from females (35%). The majority of the 
patients studied were aged between 1-9 days but the result did not differ 
significantly from other age group 24. 
 We found that the prevalence of neonatal sepsis in male was 53.71% 
Table (1) which is higher than in female 46.29 % ( Table1), and that 
confirm the fact that male gender is considered as a risk factor for 
neonatal sepsis.  
 
A study titled (Neonatal infections in England: the NeonIN surveillance 
network) Conducted by Vergnano S. and his colleagues Designed as 
prospective multicentre surveillance using a web-based database linked to 
12 English neonatal units. They measure: Incidence, age at infection, 
pathogens and antibiotic resistance profiles. They found that the 
incidence of early onset sepsis (EOS; = 48 h of age) was 0.9/1000 live 
births and the incidence of late onset sepsis (LOS; >48 h of age) was 
3/1000 25. 
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In our study, the incidence of early neonatal sepsis to late neonatal sepsis 
were 8.73 % and 91.27 % respectively (Table 2), this high incidence of 
late neonatal sepsis indicate that the neonates acquired the causative 
microorganism from the surrounding environment either from hospital or 
home and that may be due to improper handling of the neonate or the low 
hygiene at home. 
 
Complete Blood Count (CBC) is one of the diagnostic methods of 
infectious diseases. 
In our study the CBC was performed for all cases 100% (Table 3).   
 
The diagnosis of neonatal sepsis, the isolation of causative organism, and 
the proper selection of the most effective and efficient antimicrobial 
depend mainly on blood culture and urine culture. 
In study conducted From February 2003 to December 2004, at Neonatal 
Unit of Ghurki Trust Teaching Hospital, attached with Lahore Medical & 
Dental College Lahore by Rizwan Waseem and his colleagues,  
The objectives were to find out the bacterial pathogens in neonatal sepsis 
and to determine antimicrobial sensitivity patterns of these pathogens. 
 They found that Escherichia coli was the commonest organism isolated, 
followed by Klebsiella, Pseudomonas, Staph. aureus, Staph epidermidis, 
Enterobacter, Acinobacter, Serratia and Streptococcus .E. Coli constituted 
33.37% of the early onset group, and 33.33 of late onset group.  
Klebsiella constituted 34.37% and 22.22% while Pseudomonas 12.5% 
and 13.88% of early and late onset groups respectively. Enterobacter spp. 
was present only in the late, while Streptococcus in the early onset sepsis. 
Acinobacter, Staph. aureus and Staph. Epidermidis affected both the early 
and late onset groups 26. 
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In our study 0% of the studied cases had been blood  cultured (Table4), 
and 0% urine cultured (Table5), no  isolation of the causative organisms 
and the selection of the antimicrobial treatment was done empirically, this 
let to  irrational use of antibiotics which will lead to emergency of 
resistance to these agents used. 
 
The selection of the best antimicrobial treatment based on the sensitivity 
of the isolated organism to the specific antimicrobial agent. 
The study above mentioned26 was also aimed to determine the sensitivity 
of the isolated pathogens to different antimicrobial agents. 
They found that all of the isolated were having a low sensitivity to 
Ampicillin, Gentamicin and Cefotaxime, while most of the organisms 
were sensitive to Ceftazidime, Amikacin and Imipenem. E. coli showed 
sensitivity of 14.70% to Ampicillin, 17.6% to Gentamicin, 41.17% to 
Cefotaxime, 61.76% to Amikacin, 79.4% to Ceftazidime and 97.05% to 
Imipenem. 
Klebsiella and Pseudomonas also showed a low sensitivity to Ampicillin, 
Gentamicin, and Cefotaxime, while good sensitivity to Amikacin, 
Ceftazidime and Imipenem 26. 
In our study no blood culture 0%(Table 4), and/or urine culture 0%Table 
(5) were performed, so neither isolation of causative microorganisms nor 
sensitivity test 0%(Table 6) were done.  Antimicrobial agents were 
chosen regarding less to causative organisms and this also shows an 
irrational use of antibiotics in the hospital and of course the emergence of 
resistance to the used agents. 
 
 We found that supportive treatments (Intravenous fluids, Human 
albumin, Parental Nutrition, Thermal and Incubation) were received by 
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all of the sample patients 100% ( Table 7) as recommended in 
management of neonatal sepsis for maintenance of neonate vital signs. 
 
  A study about the Empirical treatment of neonatal sepsis: are the current 
guidelines adequate? Was conducted by Muller-Pebody B and his 
colleagues the objectives of the study were to use national laboratory 
surveillance data to determine whether pathogens responsible for neonatal 
bacteraemia were sensitive to nationally recommended antibiotic 
regimens. 
All reports of neonatal bacteraemia received by the Health Protection 
Agency's voluntary surveillance scheme in England and Wales from 
January 2006 until March 2008, were extracted from the database. 
Organisms were ranked by frequency, and proportions susceptible to 
antimicrobials recommended for empirical treatment of neonatal sepsis 
were determined. 
They found that More than 94% of organisms (early-onset) were 
susceptible to regimens involving combinations of  Penicillin with either 
Gentamicin, Amoxicillin combined with Cefotaxime or Cefotaxime 
monotherapy. More than 95% of organisms (late-onset) were susceptible 
to Gentamicin with either Flucloxacillin or Amoxicillin and Amoxicillin 
with Cefotaxime, but only 79% were susceptible to Cefotaxime 
monotherapy. 
And concluded that Current guidelines for empirical therapy in neonates 
with sepsis are appropriate. However, Gentamicin-based regimens should 
be used in preference to Cefotaxime-based treatments, because of lower 
levels of susceptibility to Cefotaxime and the need to avoid exerting 
selective pressure for resistance 27.  
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In our study the antimicrobials agent used were as following: 
 
The most of the patients 65.93%  were received the combination of 
Cefotaxime and Ampicillin plus Cloxacillin (Ampiclox) (Table 8), 
and it was prescribed regardless to blood culture, urine culture and 
sensitivity tests, this regimen which contain Ampicillin and Cloxacillin  
was used for the concern about Ampicillin which was recommended by 
the most of  protocols  in combination with either Gentamycin  injection 
,Amikacin injection or third generation cephalosporin (eg.Cefotaxime), 
but the presence of Cloxacillin  make it one of the drawbacks of this 
regimen because it will lead to development of resistant organisms, the 
Gentamycin-based regimen (in combination with Benzyl Penicillin inj) 
was prescribed for only 6.6%  of the patients( Table8), and as mentioned 
in the above study conclusion27  ,the Gentamicin-based regimens should 
be used in preference to Cefotaxime-based treatments, because of lower 
levels of susceptibility to Cefotaxime and to avoid development of 
resistant microorganisms 27.  
The second most used combination was Cefotaxime inj+Apmiclox inj 
(Cloxacillin+Ampicillin) +Vancomycin inj represents 13.10% (Table 8) 
which also prescribed regardless to blood culture, urine culture and 
sensitivity tests, the addition of  Vancomycin  injection to this regiment 
due to susceptibility of  MRSA infection, Vancomycin was added after 
the delay in recovery of patients. The use of this combination must be 
restricted for resistant cases and after isolation of causative organism and 
sensitivity test which was totally ignored in all of these cases, and the 
consequences of this irrational use of antibiotics are the generation of 
resistant microorganism and the high economical burden on hospital 
budget. 
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The third most used combination was Cefotaxime inj+Apmiclox 
inj(Cloxacillin+Ampicillin) +Metronidazole inj 7.5% (Table8), 
The Metronidazole was added to cover aerobic and anaerobic 
microorganism but also regardless the causative agent. 
 
Combination of Gentamycin injection and Benzyl Penicillin injection 
prescribed for only 6.6% of patients (Table8), this regimen which 
Gentamycin-based  was recommended by lot of authorities28, but it was 
rarely used and this maybe due to the fair of treating doctors from 
resistant organisms and the severe illness of the neonates admitted  to the 
hospital .  
 
Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin)+Meropenem inj 
combination prescribed foe 3.5% of the patients(Table 8), this 
combination was also used regardless the isolation of the causative 
organisms and Meropenem inj was added due to the delay in response to 
the Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin) combination 
and the severe illness of the neonate , in spite of  the fact that it’s reserved 
drug and not recommended for use in pediatric patients, and can be used 
for patients hospitalized for long periods and patients with complicated 
conditions who tried other antibiotics without improvement. 
 
Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin) +Amikacin 
combination used for 2.2% of the patients (Table 8), to cover most of 
organism, it was used regardless the isolation of causative organism and 
this also may lead to emergence of resistance. 
 
Ceftriaxone inj+ Apmiclox inj(Cloxacillin+Ampicillin) combination used 
for 0.9% of the patients (Table 8), it wasn’t recommended as first line but 
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due to lack of knowledge of causative organism it was used as empiric 
therapy and this also may lead to emergence of resistance. 
 
Cefotaxime inj+Apmiclox inj(Cloxacillin+Ampicillin) +Acyclovir 
inj+Fluconazole inj combination used for 0.2% of the patients (Table 8) 
to cover all suspected infections bacterial, fungal and viral (Neonatal 
sepsis can be of bacterial and/or fungal  and/or viral infections) 8,  this is 
considered as empiric therapy to cover all possible infections . 
 
There are different protocols regarding the use of antimicrobial in 
managing neonatal sepsis, here we will stack to the protocol approved 
and used in the hospital which is the study area. 
 
There are different lines for treatment of neonatal sepsis based on the type 
of infection and the causative organism as stated in the introduction, the 
follow-up of these lines were studied, and the results were: 
 
Early onset neonatal sepsis first line (Ampicillin or Benzyl Penicillin 
injection and Gentamycin) used for 6.6% of the patients. 
Late onset neonatal sepsis first line (Flucloxacillin and Amikacin) was 
not used for any case 0% (table 8). 
Late onset neonatal sepsis second line (to the first line adds 
Cefotaxime/Ceftazidime) was not used for any case 0% (table 8). 
Late onset neonatal sepsis third line (Vancomycin 13.10% and Amikacin 
2.2%) (Table 8). 
The hospital protocol was followed in 21.9% of the studied cases. 
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The duration of treatment as mentioned in the introduction vary from 48 
hours up-to more than three weeks. 
Gathwala G, and his colleagues conducted a study titled: Ten days vs. 14 
days antibiotic therapy in culture-proven neonatal sepsis. The objective of 
the study was to compare the effectiveness of a 10-day course of 
antibiotic therapy with the conventional 14-day course in blood culture-
proven neonatal sepsis. They concluded that Ten-day antibiotic therapy is 
as effective as 14-day therapy in blood culture-proven neonatal sepsis, if 
the infant has achieved clinical remission by Day 7 of therapy 28. 
 
In our study the duration of treatment for the studied cases were: 17.46%  
of patients were treated for  0 – 48 hours ,  65.50% of patients were 
treated  for 3 – 7 days which represent the most common duration of 
treatment   and 17.04%  of studied cases treated for more than 7 days due 
to very severe sepsis   (Table 9). 
 
Outcomes of the treatment for the studied cases were found to be as 
following: 
The improved and cured and discharged neonates were 74.67% of the 
studied cases Table (10). 
The percent of the patient not cured was 25.33% Table (10) which is high 
percent that indicates the need for establishing strategies to reduce this 
high mortality rate. 
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Chapter 4: 
 
 Conclusion and Recommendations:- 
 
 
 
4.1-Conclusion: 
 
 
Mortality rate due to neonatal sepsis at Dr.Gaffar Ibnauf specialized 
children's hospital – Khartoum – Sudan was 24% of the total death in the 
hospital, 562 patients were diagnosed and treated as neonatal sepsis, 120 
patients out of the 562 patients were dead which represents 21.35% of the  
neonatal sepsis patients, the diagnosis was done depending mainly on 
clinical signs and CBC, all patients received supportive treatment , the 
selection of antimicrobial was empirically not based on blood or urine 
culture or sensitivity tests, the most used combination was 
Cefotaxime+Ampicillin+Cloxacillin which represent 65.93% (Table 8) 
for all types of neonatal sepsis regardless the causative organism, some 
cases treated using other combination when the above mentioned 
treatment failed to treat the case effectively and efficiently, which include 
Cefotaxime+Ampicillin+Cloxacillin+Vancomycin combination used in 
13.1% (Table 8), in which vancomycin was added after the suspicion of 
MRSA without cultures, Cefotaxime inj+Apmiclox 
inj(Cloxacillin+Ampicillin) +Metronidazole inj combination used for 
7.5% (Table8) to cover anaerobic infections, Cefotaxime inj+Apmiclox 
inj(Cloxacillin+Ampicillin) +Acyclovir inj+Fluconazole inj  used in 0.2% 
(Table 8) for very ill neonate to cover as possible infections. Cefotaxime 
inj+Apmiclox inj(Cloxacillin+Ampicillin)+Meropenem inj combination 
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prescribed for 3.5% (Table 8). Cefotaxime inj+Apmiclox inj 
(Cloxacillin+Ampicillin) +Amikacin combination used for 2.2% of the 
sample cases (Table8). Ceftriaxone inj+ Apmiclox inj 
(Cloxacillin+Ampicillin) combination used for only 0.9% of the patients 
(Table 8).  Finally Benzyl penicillin inj+Gentamycin inj combination 
which used for 6.6% of the patients (Table 8). 
The protocol of the treatment of neonatal sepsis was followed only in 
21.9% of the studied cases and that indicate to an irrational use of 
antibiotics in most of the studied cases,  
The outcomes of the treatment was 74.67% of the patients were cured and 
25.33% of the patients were not cured (died) either due to improper 
selection of antimicrobial or the severity of the illness in which the 
patients arrived the hospital in a complicated conditions and very severe 
sepsis. 
The records keeping system in the hospital was proper, but more effort is 
needed to use computer database to make it easier to evaluate different 
treatment for different diseases and to easy the access to patient's 
medication records without violence of privacy and confidentiality of 
patients. 
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4.2-Recommendations: 
 
New strategies should be established in order to reduce this high 
mortality rate and the irrational use of antibiotics. 
The selection of antimicrobial for treatment of neonatal sepsis must be 
based on the type of the infection and the isolation of causative organism 
through blood culture, urine culture and sensitivity tests. 
 Pharmacist as health care provider and because they are familiar with 
medication must be more involved in prevention of irrational use of 
antibiotics, so antimicrobial stewardship team is to be created which 
include at least infectious disease physician, clinical pharmacist with 
infectious diseases training  and clinical microbiologist to optimize the 
selection of appropriate antimicrobial agents, dose and duration and that 
will lead to best outcomes and reduce emergency of resistance due to 
irrational use of antimicrobial agents. 
Soft copies of patient's medication records must be kept to make it easier 
to assess each treatment individually and to easy the access by treating 
staff with out violation of privacy and confidentiality of the patients.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
 
 
 
 
References: 
 
1. Gotoff SP. Neonatal Sepsis and meningitis: in: Nelson textbook of 
Pediatrics. (15th Edition).Eds Behraman RE, Kleigman RM, Arbin AM. 
Philadelphia, WB Saunders company 1996: PP: 528-537. 
 
2. Agrawal R, Sarkar N, Deorary AK and Paul VK.Sepsis in newborn. 
Ind. J. Paediatric Dec 2001:68: 1143-1147. 
 
3. Cloberty J. P. & stark R. (Ed). Manual of Neonatal Case. 1998. 
 
4. Bizzarro MJ RC, Baltimore RS, Gallagher PG Seventy-Five Years of 
Neonatal Sepsis at Yale: 1928–2003 Pediatrics 2005; 116:595-602  
5. Escobar GJ D-kL, Armstrong MA, et al. Neonatal sepsis workups in 
infants' = 2,000 grams at birth: a population-based study. Pediatrics 2000; 
106:256-65. 
6. Baker CJ NV, Edwards MS. Group B streptococcal infections. In: 
Remington JS KJ, ed. Infectious diseases of the fetus and newborn infant. 
6 ed. Philadelphia: Saunders; 2005. 
7. Larsen JW SJ. Group B Streptococcus and pregnancy: a review. Am J 
Obstet Gynecol 2008; in press. 
8.  Baltimore R. Neonatal sepsis: epidemiology &management. Paediatr 
Drugs 2003; 5:723. 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
9. Benjamin DK Jr SB. Infection in late preterm infants. Clin Perinatol 
2006; 33:871-82. 
10. Kempley ST; Murdoch E. Splanchnic homodynamic disturbance in 
perinatal sepsis Arch Dis Child Fetal Neonatal Ed 2000; 83(2):F139-42. 
11. Haque KN. Infection and immunity in newborn. In: Mc Intosh HP, 
Smyth R (eds). Forfar and Arneil’s Text Book of Pediatrics. 6th edn. 
Edinburg: ChurchillLivingstone, 2003; pp. 336–53. 
 
12. Carcillo JA FA. Clinical practice parameters for hemodynamic 
support of pediatric and neonatal patients in septic shock. Crit Care Med 
2002;30:1365-70. 
13.      Neu J. Gastrointestinal development and meeting the nutritional 
needs of premature infants. Am J Clin Nutr 2007;85:629S-34S. 
 
14. Clark RH BB, Spitzer AR, Gerstmann DR Empiric Use of Ampicillin 
and Cefotaxime, Compared With Ampicillin and Gentamicin, for 
Neonates at Risk for Sepsis Is Associated With an Increased Risk of 
Neonatal Death Pediatrics 2006;117:67-74 
 
15. Isaacs D, Barfield CP, Grimwood K, McPhee AJ, Minutillo C, 
Tudehope DI. Systemic bacterial and fungal infections in infants in 
Australian neonatal units. Medical Journal of Australia 1995;162:198-
201. 
 
16. Stoll BJ, Gordon T, Korones SB et al. Early-onset sepsis in very low 
birth weight neonates: a report from the NICHHD Neonatal Research 
Network. Journal of Pediatrics 1996;129:1093- 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
1099. 
 
17. Rennie JM, Roberton NRC. Textbook of Neonatology (3rd Edition). 
Appendix 11. 
 
18. Faix RG, Kovarik SM, Shaw TR, Johnson RV. Mucocutaneous and 
invasive candidiasis among very low birth weight infants in intensive care 
nurseries: a prospective study. Pediatrics 1989;83:101-107. 
 
19. Sharp AM, Odds FC, Evans EG. Candida strains from neonates in a 
special care baby unit.Archives of Disease in Childhood 1992;67:48-52. 
 
20. Kaufman D, Fairchild KD. Clinical Microbiology of Bacterial and 
Fungal sepsis in Very Low Birth.Weight infants. Clinical Microbiology 
Reviews July 2004, p.638-680. Vol. 17, No. 3 
21. J Coll Physicians Surg Pak. 2003 Nov;13(11):629-32.  
22. Arch Dis Child Fetal Neonatal Ed doi:10.1136/adc.2009.178483. 
23. Oxford Journals Medicine Journal of Antimicrobial Chemotherapy 
Volume 65, Issue6 Pp. 1270-1275.  
 DO Awoniyi, SJ Udo and OO Oguntibeju .African Journal of 
Microbiology Research Vol. 3(6) pp. 385-389, July, 2009 . 
 
25. Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts 
T, Robinson MJ, Collinson A, Heath PT. Arch Dis Child Fetal Neonatal 
Ed. 2011 Jan;96(1):F9-F14. Epub 2010 Sep 27. 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
26.  Rizwan W ,  Tahira S , Muhammad K and Abdul Waheed Q. 
Professional Med J Dec 2005; 12(4): 451-456. 
27.  Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson 
KL, Sharland M; iCAP Group (Improving Antibiotic Prescribing in 
Primary Care). Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F4-8. 
Epub 2010 Jun 28. 
28. Gathwala G, Sindwani A, Singh J, Choudhry O, Chaudhary U. J Trop 
Pediatr. 2010 Dec;56(6):433-5. Epub 2010 Feb 25. 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
